The INTRICATE program has brought forward a strategic AI-powered nanotechnology platform to develop assets in the field of neuroscience, musculoskeletal disease (rheumatology, orthopaedics) and chronic degenerative diseases.
Using several building blocks, such as polypeptides and nanotech biopolymers, this unique platform can generate assets with selectable biological and mechanical properties.
These assets can achieve their disease-modifying effect through direct interactions at the cellular level, or indirectly as a tuneable vehicle for combination products.